King Abdulaziz University

kau.edu.sa

Total trials

93

Active

18

Phase 3

6

Total enrollment

9,554

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Dexamethasone Sodium Phosphate1
Resin infiltration1
Vanish XT varnish1
Silver diamine Fluoride 38%1
Silver diamine fluoride- potassium iodide1
Injectable Platelet Rich Fibrin1
3D-printed Orthognathic Surgical Simulation1
2D Visual Representations of Skeletal Movements in Orthognathic Surgery1
A- PRF1

Next readouts

  • 2025-05-30
  • 2025-06-30
  • 2025-06-30
  • 2025-08-30
  • 2026-03
  • 2026-05-31

Top conditions

  • Dental Caries11
  • Pain3
  • Behavior3
  • COVID-193
  • Gingivitis2
  • Pain Perception of the New Device2
  • Polycystic Ovary Syndrome2
  • Orthodontic Appliance Complication2

Frequently asked questions about King Abdulaziz University

How many clinical trials does King Abdulaziz University have on ClinicalTrials.gov?
King Abdulaziz University is listed as the lead sponsor on 93 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
How many of King Abdulaziz University's trials are in Phase 3?
6 of King Abdulaziz University's trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does King Abdulaziz University focus on?
King Abdulaziz University's most-studied conditions on ClinicalTrials.gov are Dental Caries, Pain, Behavior, COVID-19, Gingivitis.
When are King Abdulaziz University's next clinical trial readouts?
King Abdulaziz University has 6 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Dexamethasone Submucosal Injection After Surgical Extraction of Lower Impacted Third Molars on Trismus and Edema”, expected around 2025-05-30.